PSMD1 and COVID-19: Analysis of human PBMCs showed viral persistence in the form of fragmented SARS-CoV-2 RNA and the presence of S1 viral proteins in the post-acute sequelae of COVID-19 patients for up to 15 months post-acute infection (60).